# Pilot RCT of Therapeutic Hypothermia Plus Neuromuscular Blockade in COVID-19 Patients With ARDS

> **NCT03376854** · PHASE2 · WITHDRAWN · sponsor: **University of Maryland, Baltimore**

## Conditions studied

- Respiratory Distress Syndrome, Adult
- Sars-CoV2

## Interventions

- **DEVICE:** Hypothermia
- **DRUG:** Neuromuscular Blocking Agents
- **DEVICE:** Standard of Care

## Key facts

- **NCT ID:** NCT03376854
- **Lead sponsor:** University of Maryland, Baltimore
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-05-01
- **Primary completion:** 2021-04-27
- **Final completion:** 2021-04-27
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Competition from other studies and initiation of a larger multi center trial
- **Last updated:** 2021-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03376854

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03376854, "Pilot RCT of Therapeutic Hypothermia Plus Neuromuscular Blockade in COVID-19 Patients With ARDS". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03376854. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*